Screening for Osteoporosis to Prevent Fractures

Authors:

Top Cited Papers
Open Access
Abstract
The primary rationale for screening for osteoporosis is to identify persons who would benefit from pharmacotherapy to reduce the incidence and morbidity from fragility fractures, which are defined as fractures resulting from low-energy trauma (eg, a fall from standing height or less). In 2018, the US Preventive Services Task Force (USPSTF) recommended screening with bone measurement testing in women 65 years or older and in postmenopausal women younger than 65 years with increased risk of osteoporosis as determined by a formal clinical risk assessment tool.1 The evidence was insufficient for the USPSTF to assess the benefits and harms of screening in men (I statement).1 This update review evaluated the current evidence on screening to inform an updated recommendation by the USPSTF.

This publication has 211 references indexed in Scilit: